Chevy Chase Trust
TEVA icon

Chevy Chase Trust’s Teva Pharmaceuticals TEVA Stock Holding History

Chevy Chase Trust’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-12,239
Closed -$215K – 697
2017
Q3 		$215K Buy
12,239
+5,497
+82% +$124K ﹤0.01% 642
2017
Q2 		$224K Buy
6,742
+469
+7% +$14.5K ﹤0.01% 631
2017
Q1 		$201K Buy
6,273
+207
+3% +$7.06K ﹤0.01% 636
2016
Q4 		$220K Sell
6,066
-2,933
-33% -$117K ﹤0.01% 635
2016
Q3 		$414K Sell
8,999
-43,073
-83% -$2.25M ﹤0.01% 584
2016
Q2 		$2.62M Sell
52,072
-9,299
-15% -$495K 0.01% 526
2016
Q1 		$3.28M Sell
61,371
-3,929
-6% -$231K 0.02% 511
2015
Q4 		$4.29M Sell
65,300
-5,351
-8% -$331K 0.03% 493
2015
Q3 		$3.99M Sell
70,651
-15,162
-18% -$983K 0.02% 492
2015
Q2 		$5.07M Sell
85,813
-10,294
-11% -$635K 0.03% 479
2015
Q1 		$5.99M Sell
96,107
-30,055
-24% -$1.75M 0.04% 467
2014
Q4 		$7.26M Sell
126,162
-10,860
-8% -$605K 0.05% 414
2014
Q3 		$7.37M Sell
137,022
-598
-0.4% -$31.7K 0.05% 402
2014
Q2 		$7.21M Sell
137,620
-7,672
-5% -$392K 0.05% 394
2014
Q1 		$7.68M Sell
145,292
-3,667
-2% -$169K 0.06% 368
2013
Q4 		$5.97M Buy
148,959
+25,781
+21% +$1.02M 0.04% 421
2013
Q3 		$4.65M Buy
123,178
+53,127
+76% +$2.07M 0.04% 452
2013
Q2 		$2.75M Buy
+70,051
New +$2.73M 0.02% 503

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BC
Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return

Chevy Chase Trust's TEVA Position: Q4 2017 in Review

Chevy Chase Trust sold out of Teva Pharmaceuticals (TEVA) in Q4 2017, closing a stake of 12,239 shares — an estimated $215K sold.

Chevy Chase Trust first reported a position in TEVA in Q2 2013 and held it in 18 quarters. The position peaked at $7.68M in Q1 2014. 507 funds tracked by Wall St. Rank hold TEVA as of Q4 2017.

  • Chevy Chase Trust reported no remaining Teva Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Chevy Chase Trust sold 12,239 Teva Pharmaceuticals shares in Q4 2017, an estimated $215K.
  • Chevy Chase Trust first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 18 quarters.
  • Chevy Chase Trust's Teva Pharmaceuticals position peaked at $7.68M in Q1 2014.
  • 507 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2017.

Based on Chevy Chase Trust's 13F filing for Q4 2017, filed 22 Jan 2018.